One out of every seven men in the U.S. will be diagnosed with prostate cancer in their lifetime.
Advances in diagnosis and treatments have improved the prognosis for patients.
Starting a treatment plan early is important, and our diagnostic methods help achieve this.
Our continuous focus on surgical advances and cancer treatments is a significant benefit for patients.